HCR Wealth Advisors »

Black Diamond Therapeutics shares owned by HCR Wealth Advisors

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by HCR Wealth Advisors from 13F filings

Historical chart of HCR Wealth Advisors investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by HCR Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by HCR Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $66k 27k 2.43

More positions owned by HCR Wealth Advisors

Apple Common Stock (AAPL)
Vanguard Growth Index Fund ETF Etf (VUG)
Vanguard High Dividend Yield Index Fund ETF Etf (VYM)
Nvidia Corp Common Stock (NVDA)
Vanguard Extended Market ETF S &P Compl Common Stock (VXF)
iShares Core S&P 500 ETF Etf (IVV)
Alphabet Common Stock (GOOGL)
Microsoft Common Stock (MSFT)
First Trust Preferred Securities and Income ETF Etf (FPE)
iShares Core MSCI Emerging ETF Etf (IEMG)
Ametek Common Stock (AME)
iShares Core S&P Small-Cap ETF Etf (IJR)
Meta Platforms Common Stock (META)
Palo Alto Networks Common Stock (PANW)
Amazon.Com Common Stock (AMZN)

View all positions for HCR Wealth Advisors

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
NEA Management Company
Vanguard Group
Acadian Asset Management
Marshall Wace
Siren
Arrowstreet Capital, Limited Partnership
Jane Street
Renaissance Technologies
BlackRock
Vestal Point Capital
Dimensional Fund Advisors
Millennium Management
Connor, Clark & Lunn Investment Management
AWM Investment Company

View all funds holding Black Diamond Therapeutics